BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
9/26/2024 10:17:47 AM | Browse: 103 | Download: 791
 |
Received |
|
2024-06-05 11:28 |
|
Peer-Review Started |
|
2024-06-05 11:28 |
|
First Decision by Editorial Office Director |
|
2024-07-02 05:35 |
|
Return for Revision |
|
2024-07-02 05:35 |
|
Revised |
|
2024-08-07 14:57 |
|
Publication Fee Transferred |
|
2024-08-14 12:20 |
|
Second Decision by Editor |
|
2024-08-12 05:15 |
 |
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2024-08-12 09:31 |
|
Articles in Press |
|
2024-08-12 09:31 |
|
Edit the Manuscript by Language Editor |
|
2024-08-22 21:00 |
|
Typeset the Manuscript |
|
2024-08-29 03:19 |
|
Publish the Manuscript Online |
|
2024-09-26 10:17 |
| ISSN |
1948-5204 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Observational Study |
| Article Title |
Small particle drug-eluting beads-transarterial chemoembolization combined with targeted therapy in the clinical treatment of unresectable liver cancer
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Jing-Song Qi, Peng Zhao, Xiao-Bo Zhao, Yong-Li Zhao and Ying-Chang Guo |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Jing-Song Qi, MMed, Associate Chief Physician, Department of Interventional, The First Affiliated Hospital of Xinxiang Medical University, No. 88 Jiankang Road, Weihui, Xinxiang 453100, Henan Province, China. jingsong05010403@163.com |
| Key Words |
Small particle; Drug-eluting beads-transarterial chemoembolization; Sorafenib; Treatment; Unresectable liver cancer |
| Core Tip |
This study compared the efficacy of single-agent sorafenib targeted therapy with its combination with small particle drug-eluting beads-transarterial chemoembolization (DEB-TACE) in patients with unresectable liver cancer. The results demonstrate that combining small particle DEB-TACE with sorafenib significantly enhances both short- and long-term treatment outcomes compared to single-agent therapy. This combination approach improves liver function, reduces tumor marker levels, boosts overall treatment efficacy, and enhances patient prognosis. This approach is safe, reliable, and holds significant clinical utility. |
| Publish Date |
2024-09-26 10:17 |
| Citation |
Qi JS, Zhao P, Zhao XB, Zhao YL, Guo YC. Small particle drug-eluting beads-transarterial chemoembolization combined with targeted therapy in the clinical treatment of unresectable liver cancer. World J Gastrointest Oncol 2024; 16(10): 4157-4165 |
| URL |
https://www.wjgnet.com/1948-5204/full/v16/i10/4157.htm |
| DOI |
https://dx.doi.org/10.4251/wjgo.v16.i10.4157 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.
